P53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients

• Main Authors: Bourdon, J.-C, Khoury, M.P, Diot, A, Baker, L, Fernandes, K, Aoubala, M, Quinlan, P, Purdie, C.A, Jordan, L.B, Prats, A, Lane, D.P, Thompson, A.M
• Other Authors: MEDICINE
• Format: Article
• Published: 2020
• Subjects: mutant protein; protein p53; protein p53beta; protein p53gamma; tumor marker; unclassified drug; isoprotein; adult; aged; article; breast cancer; cancer patient; cancer recurrence; cancer survival; cohort analysis; controlled study; disease marker; female; gene mutation; human; major clinical study; overall survival; primary tumor; prognosis; protein analysis; protein expression; reverse transcription polymerase chain reaction; wild type; breast tumor; genetics; middle aged; mortality; mutation; pathology; recurrent disease; survival; very elderly; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Middle Aged; Mutation; Prognosis; Protein Isoforms; Recurrence; Survival Analysis; Tumor Suppressor Protein p53
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/183260
• Institution: National University of Singapore

10.1186/bcr2811